Definition of the concept of novel food

Judgment of the Court of Justice of the European Union of 25 May 2023

Anna Gerboles

Capsulas Nº 242

Last May, the Court of Justice of the European Union (CJEU) delivered a judgment in case C-141/22, which arose from a preliminary reference by the Bezirksgericht Gratz (Austria). The judgment concerns the definition of “novel food” in Regulation 2015/2283 on novel foods (Novel Foods Regulation). Novel foods are increasingly present in our diet. This is...
Read More

Oferta conjunta y competencia

Xavier Moliner

El Global

Es más o menos frecuente que para presentar una oferta a una licitación pública dos o más compañías tengan que asociarse, porque cada una de ellas por sí misma no puede ejecutar todas las prestaciones que son objeto del contrato. En España, la forma en que generalmente se produce la cooperación entre empresas para participar...
Read More

Global Legal Insights to: Pricing & Reimbursement 2023

Jordi Faus, Lluís Alcover and Joan Carles Bailach

Global Legal Group

The sixth edition of Pricing & Reimbursement has been recently published and just like last year Jordi Faus, with the collaboration of Lluís Alcover and Joan Carles Bailach, has been in charge of the chapter dedicated to pricing and reimbursement in Spain. GLI Pricing & Reimbursement 2023 includes the following sections for each of the...
Read More

El medicamento en lo tribunales en el año 2022

Jordi Faus, Xavier Moliner, Eduard Rodellar, Lluís Alcover, Anna Gerboles, Santiago Tomas, Juan Martínez, Joan Carles Bailach, Laia Rull and Claudia Gonzalo

COMUNICACIONES EN PROPIEDAD INDUSTRIAL Y DERECHO DE LA COMPETENCIA, NÚM. 98 ENERO-ABRIL 2023

By means of this article we go through the most important decisions by Spanish andEuropean courts regarding medicinal products during the year 2022.

Is it the end of Revalmed?

About the Judgment of the National High Court of 26 June 2023

Lluís Alcover and Joan Carles Bailach

Capsulas Nº 241

Plan for the consolidation of TPRs Following the approval of a new medicine or a new indication for an already approved medicine, a process is initiated to decide whether or not the new medicine should be funded by the National Health System (NHS) and, if funded, its price (the P&R process). The P&R process is...
Read More

Medicinal products in election manifestos

About the proposals on medicinal products contained in the manifestos of the political parties for the forthcoming general elections in Spain

Joan Carles Bailach

Capsulas Nº 240

Medicinal products in election manifestos On the proposals on medicinal products contained in the manifestos of the political parties for the forthcoming general elections in Spain Background General elections will be held in Spain on Sunday 23rd July. The next government will face important challenges in relation to medicinal products, including the revision of the...
Read More

El medicamento en los programas electorales

Joan Carles Bailach

El Global

Este próximo 23 de julio la ciudadanía española con derecho a voto está llamada a las urnas para elegir el nuevo Congreso de los Diputados y el nuevo Senado. El próximo Gobierno deberá afrontar grandes retos en los próximos meses y años, especialmente en materia farmacéutica. A pesar del ruido que generan las campañas electorales,...
Read More

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información. ACEPTAR

Aviso de cookies